Androgen supplementation in older women: Too much hype, not enough data

Journal of the American Geriatrics Society

Volumn 50, Issue 6, 2002, Pages 1131-1140

  Padero, Ma Clara M ^a   Bhasin, Shalender ^a   Friedman, Theodore C ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Androgen; Bone density; Cognitive; Menopausal women; Muscle mass; Sexual

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; ESTRADIOL; METHYLTESTOSTERONE; PRASTERONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ARTICLE; BODY COMPOSITION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; ELDERLY CARE; HORMONAL THERAPY; HUMAN; MENOPAUSE; MUSCLE MASS; MUSCLE STRENGTH; POSTMENOPAUSE; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; VIRILIZATION; WELLBEING;

AGED; ANDROGENS; BONE DENSITY; COGNITION; FEMALE; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; MUSCULOSKELETAL PHYSIOLOGY; POSTMENOPAUSE; SEXUALITY; TESTOSTERONE;

EID: 0036087853     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50273.x     Document Type: Article

References (113)

1. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women
2. Further study of factors affecting the metabolic clearance rate of testosterone in man
3. Issues concerning androgen replacement therapy in postmenopausal women
4. Prolactin and adrenal androgen secretion
5. Serum androstenedione and testosterone levels during the menstrual cycle
6. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer
7. Hormonal profiles after the menopause
8. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults
9. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland
10. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition
11. The role of androgen in the maintenance of sexual functioning in oophorectomized women
12. Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells - Evidence of its presence in melanocytes
13. Estrogens and health in males
14. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
15. Intracrinology
16. Intracrinology: The basis for the rational design of endocrine therapy at all stages of prostate cancer
17. Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma
18. Clinical utility of sex hormone-binding globulin measurement
19. A critical evaluation of simple methods for the estimation of free testosterone in serum
20. An extraordinarily inaccurate assay for free testosterone is still with us
21. Exogenous androgens in postmenopausal women
22. Reduced androgen levels in adult turner syndrome: Influence of female sex steroids and growth hormone status
23. Androgen deficiency in women with hypopituitarism
24. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression
25. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test
26. Psychosexual effects of menopause: Role of androgens
27. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause
28. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause
29. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea
30. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy
31. DHEA replacement in women with adrenal insufficiency-pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition
32. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women
33. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
34. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
35. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - A clinical research center study
36. Testosterone replacement increases fatfree mass and muscle size in hypogonadal men
37. Proof of the effect of testosterone on skeletal muscle
38. The dose-dependent effects of testosterone on sexual function and on muscle mass and function
39. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women
40. Muscle strength and serum testosterone, cortisol and SHBG concentrations in middle-aged and elderly men and women
41. The effect of testosterone propionate on nitrogen, electrolyte, water and energy metabolism in eunuchoidism
42. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
43. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study
44. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
45. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women
46. Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover, and exercise capacity
47. Role of astroglia and insulin-like growth factor-I in gonadal hormone-dependent synaptic plasticity
48. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats
49. Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons
50. Effects of estrogen on cell growth and fibroblast growth factor receptor induction in MtT/Se cells
51. Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors?
52. Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons
53. Estrogen: Nontranscriptional signaling pathway
54. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons
55. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study
56. Neural androgen receptor regulation: Effects of androgen and antiandrogen
57. Androgen dependent brain differentiation and life span
58. Sex differences in the distribution of androgen receptors in the human hypothalmus
59. A prospective study of dehydrepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study
60. Endogenous sex hormones and cognitive function in older men
61. Curvilinear relationship between testosterone and spatial cognition in humans: Possible influence of hand preference
62. Sex hormone-related variations of cognitive performance in Kung San hunter-gatherers of Namibia
63. Testosterone influences spatial cognition in older men
64. Cognitive function and endogenous sex hormones in older women
65. The relationship between testosterone levels and cognitive ability patterns
66. The relationship between androgen levels and human spatial abilities
67. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial
68. Testosterone supplementation improves spatial and verbal memory in healthy older men
69. Testosterone administration improves spatial and verbal memory in normal men
70. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities
71. Gender differences in behaviour: Activating effects of cross-sex hormones
72. Activating effects of cross-sex hormones on cognitive functioning: A study of short-term and long-term hormone effects in transsexuals
73. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
74. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
75. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line
76. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
77. Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor
78. Hormone replacement therapy and fractures in older adults
79. Androgens and bone: Clinical implications for menopausal women
80. The pathophysiological implications of circulating androgens on bone mineral density in a normal female population
81. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
82. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause
83. Low plasma androgens in women with systemic lupus erythematosus
84. Plasma androgens in women with disseminated lupus erythematosus
85. Sex-dependent systemic lupus erythematosus-like syndrome in (NZB X SJL)F1 mice
86. Differential effects of oestrogen in murine lupus: Acceleration of glomerulonephritis and amelioration of T cell-mediated lesions
87. Effects of nandrolone decanoate in NZB/W mice treated concomitantly with maintenance doses of dexamethasone sodium phosphate
88. Effects of nandrolone decanoate or testosterone decanoate on murine lupus: Further evidence for a dissociation of autoimmunosuppressive and endocrine effects
89. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases-substitutes of adrenal and sex hormones
90. Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: Worsened disease after treatment with 19-nortestosterone in men and lack of improvemenr in women
91. A randomized trial of testosterone therapy in males with rheumatoid arthritis
92. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months
93. A double-blind, placebocontrolled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
94. Dehydroepiandrosterone in systemic lupus erythematosus
95. Assessing patients with lupus: Towards a drug responder index
96. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
97. Androgens in postmenopausal women: Production, possible role, and replacement options
98. Liver damage from long-term methyltestosterone
99. Clinical review 82: Androgens and the postmenopausal woman
100. The management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results
101. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women
102. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
103. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial
104. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life
105. Polycystic ovary syndrome is associated with endothelial dysfunction
106. Polycystic ovary syndrome: An endocrine and metabolic disease
107. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome
108. The effects of testosterone on insulin sensitivity in male rats
109. Androgen effect on insulin action and glucose metabolism
110. Lack of effect of dehydroepiandrosterone in obese men
111. Influence of endogenous androgens on carotid wall in postmenopausal women
112. Endogenous androgens and carotid intimal-medial thickness in women
113. Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus